Inici › EPOC › Carolina del Nord › Winston-Salem
Assaigs clínics de EPOC a Winston-Salem, NC
9 estudis de EPOC busquen participants en centres de Winston-Salem i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
ReclutantFase 3
- Research Site, Winston-Salem
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
ReclutantFase 3
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
ReclutantFase 3
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400048, Winston-Salem
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
ReclutantFase 4
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
ReclutantFase 4
- Southeastern Research Center, Winston-Salem
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
ReclutantFase 3
- Research Site, Winston-Salem
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
ReclutantFase 2/3
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
ReclutantFase 3
- GSK Investigational Site, Winston-Salem
SPIROMICS Study of Early COPD Progression (SOURCE)
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Wake Forest, Winston-Salem
Assaigs de EPOC en altres ciutats
- Philadelphia, PA23 estudis
- Miami, FL18 estudis
- Birmingham, AL17 estudis
- Boston, MA17 estudis
- Houston, TX15 estudis
- Orlando, FL15 estudis
- Baltimore, MD14 estudis
- Chicago, IL14 estudis
- Dallas, TX12 estudis
- Pittsburgh, PA12 estudis
- New York City, NY11 estudis
- Ann Arbor, MI10 estudis
Altres estudis a Winston-Salem
- Càncer (tots els tipus)19 estudis
- Leucèmia mieloide aguda18 estudis
- Càncer de mama14 estudis
- Mieloma múltiple14 estudis
- Malaltia cardiovascular14 estudis
- Càncer de pulmó de cèl·lules no petites12 estudis
- Càncer d'ovari10 estudis
- Diabetis tipus 29 estudis
- Síndromes mielodisplàsiques9 estudis
- Glioblastoma8 estudis
- Càncer de pulmó8 estudis
- Leucèmia limfàtica crònica8 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.